Entolimod
Term · Oncology and biomedicine · MLC-T-ONC-013369
A polypeptide derived from the Salmonella filament protein flagellin with potential radioprotective and anticancer activities. As a toll-like receptor 5 (TLR5) agonist, entolimod binds to and activates TLR5 thereby stimulating tumor necrosis factor production and activating nuclear factor kappa B (NF-kB). This induces NF-kB-mediated signaling pathways and inhibits the induction of apoptosis. This may prevent apoptosis in normal, healthy cells during radiotherapy of cancerous cells and may allow for increased doses of ionizing radiation. In addition, entolimod may inhibit radiation-independent proliferation in TLR5-expressing tumor cells.
| Identifier | MLC-T-ONC-013369 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | toll-like receptor 5 agonist CBLB502; TLR5 agonist CBLB502 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013369",
"term": "Entolimod",
"field": "Oncology and biomedicine",
"definition": "A polypeptide derived from the Salmonella filament protein flagellin with potential radioprotective and anticancer activities. As a toll-like receptor 5 (TLR5) agonist, entolimod binds to and activates TLR5 thereby stimulating tumor necrosis factor production and activating nuclear factor kappa B (NF-kB). This induces NF-kB-mediated signaling pathways and inhibits the induction of apoptosis. This may prevent apoptosis in normal, healthy cells during radiotherapy of cancerous cells and may allow for increased doses of ionizing radiation. In addition, entolimod may inhibit radiation-independent proliferation in TLR5-expressing tumor cells.",
"synonyms": [
"toll-like receptor 5 agonist CBLB502",
"TLR5 agonist CBLB502"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/entolimod/"
}
Record 6,718 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.